交易 Synthaverse SA - SVEP 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.005
• 长仓隔夜仓息调整: -0.02203%
• 短仓隔夜仓息调整: 0.00011%
• 隔夜调整仓息时间: 22:00 (UTC)
• 货币: PLN
• 最低成交量: 0.1
• 保证金: 20.00%
• 证券交易所: Poland
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 3.575
• 开仓: 3.57
• 1 年变化: -1.11%
• 日区间: 3.56 - 3.68

Synthaverse S.A. (WSE: STV) is a biotechnology and AI-powered drug discovery company, formerly known as Ryvu Therapeutics. The company is focused on developing small molecule therapies targeting oncology and immuno-oncology pathways. Leveraging in-house discovery platforms and international research partnerships, Synthaverse aims to deliver first-in-class or best-in-class compounds. It offers high-risk, high-reward exposure to next-generation biotech and early-stage clinical development in Europe.